Cooperative Agreement 72061725CA00003

Award Date 11/25/24
Completion Date 11/23/29
Dollars Obligated $18M
Federal Agency
US Mission in Uganda
Federal Grant Program
98.001
Assistance Type
Cooperative Agreement
Place of Performance
Uganda
Similar Awards
This $21,773,964 Cooperative Agreement awarded by the U.S. Agency for International Development (USAID) under the Foreign Assistance for Programs Overseas (CFDA 98.001) program aims to improve the quality, accessibility, affordability, and utilization of healthcare services in three highly urbanized districts of Uganda. The primary awardee, Jhpiego Corp, will work to enhance community involvement, foster an enabling environment for health service delivery, and address service delivery...
This $4,193,360 Cooperative Agreement was awarded by the U.S. Agency for International Development (USAID) under the Foreign Assistance for Programs Overseas (CFDA 98.001) grant program. The award aims to strengthen the capacity of city governments in Uganda to improve the efficiency of revenue mobilization and revenue performance. The project will run from September 2024 to August 2028 and is being implemented by Governance Systems International LIMITED, a for-profit limited liability company...
This $3,850,000 Project Grant awarded on September 18, 2023 by the U.S. Agency for International Development (USAID) under the Foreign Assistance for Programs Overseas (CFDA 98.001) program will support Maisha Healthcare, Inc., a for-profit, woman-owned small business, in scaling a digital approach to targeted malaria treatment in Uganda over a 3-year period. The funded activities are intended to promote long-term and equitable economic growth and advance U.S. foreign policy objectives globally,...
This Project Grant award of $660,000.00 was provided by the U.S. Agency for International Development (USAID) under the Foreign Assistance for Programs Overseas (CFDA 98.001) program. The award will fund the testing of community-led outreach clinics to improve health in rural areas of Uganda. The project will run from August 2024 to February 2025 and is being implemented by the non-profit organization Health Access Connect, located in Kampala, Uganda. The goal of the project is to develop and...
This Cooperative Agreement award from the U.S. Agency for International Development (USAID) under the Foreign Assistance for Programs Overseas (CFDA 98.001) program is intended to partner with the Government of Uganda to support an education system that enables all children and youth to acquire the education and skills needed to be productive members of society and promote stability. The $8,260,724 award to JSI Research & Training Institute Inc., a non-profit organization based in Boston,...
This federal Cooperative Agreement award is from the U.S. Agency for International Development (USAID) under the USAID Foreign Assistance for Programs Overseas (CFDA 98.001) program. The award aims to reduce leakages and loss of public resources, improve service delivery, and support citizens and communities to challenge corruption and demand accountability in Uganda. The total award amount is $5,611,034.00 with a period of performance from July 19, 2024 to July 18, 2028. The prime awardee is...
This Cooperative Agreement award of $17,185,597.00 from the Centers for Disease Control and Prevention (CDC) under the Global AIDS program (CFDA 93.067) aims to strengthen the technical capacity of the Uganda Ministry of Health to standardize, harmonize, and provide oversight for a sustainable public health response to HIV/AIDS, TB, and related health efforts. The 5-year project, commencing on September 30, 2024, will focus on building the ministry's ability to lead and coordinate a...
This Cooperative Agreement award from the U.S. Agency for International Development (USAID) under the Foreign Assistance for Programs Overseas program (CFDA 98.001) provides $1,360,008 over a 5-year period from October 1, 2024 to September 29, 2029. The purpose of this award is to reduce leakages and loss of public resources, improve service delivery, and support citizens and communities in Uganda to challenge corruption and demand accountability. Actionaid International Uganda, a...
This Cooperative Agreement award, provided by the U.S. Agency for International Development (USAID) under the Foreign Assistance for Programs Overseas program (CFDA 98.001), aims to achieve sustainable, equitable, and resilient health systems through locally led, evidence-driven, and context-specific approaches to health system strengthening. The $6,545,200 award, with a period of performance from December 19, 2024 to December 18, 2029, is granted to Family Health International (FHI 360), a...
The U.S. Department of State's Bureau of Population, Refugees and Migration (CFDA 19.517 - Overseas Refugee Assistance Programs for Africa) awarded a $3,250,000 Cooperative Agreement to Medical Teams International, Inc. to deliver effective, sustainable, and equitable life-saving healthcare services for refugees and the host community in Uganda. The award period is from Aug 1, 2024 to Jul 31, 2025. Medical Teams International is partnering with Handicap International and Transcultural...

This $18,348,780 Cooperative Agreement awarded by the U.S. Agency for International Development (USAID) under the USAID Foreign Assistance for Programs Overseas (CFDA 98.001) program aims to strengthen key elements of the Ugandan health system. The award focuses on improving health care financing, human resources for health, health management information systems (HMIS), and community health systems in Uganda. The prime awardee is Management Sciences for Health, Inc. (MSH), a non-profit organization with extensive experience in global health technical assistance and program implementation. MSH has sub-awarded portions of the work to several Ugandan organizations, including the Uganda Protestant Medical Bureau, the Registered Trustees of the Uganda Episcopal Conference, and the Uganda Healthcare Federation LIMITED, to support their targeted activities within the broader health system strengthening objectives. The award has a performance period from November 2024 to November 2029.

Generated 7/15/25, 8:06 AM